We are live on ! Find out more
FPS

Fieldpoint Private Securities Portfolio holdings

AUM $344M
1-Year Est. Return 7.21%
This Fund
S&P 500
This Quarter Est. Return
-12.46%
1 Year Est. Return
-7.21%
3 Year Est. Return
+47.17%
5 Year Est. Return
+78.97%
10 Year Est. Return
AUM
$344M
AUM Growth
-$141M
Cap. Flow
-$78.3M
Cap. Flow %
-22.73%
Top 10 Hldgs %
23.05%
Holding
1,793
New
93
Increased
202
Reduced
1,081
Closed
244

Sector Composition

Rank Sector Weight
1 Technology 15.14%
2 Financials 9.93%
3 Healthcare 9.62%
4 Industrials 4.68%
5 Consumer Discretionary 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNA icon
626
Moderna
MRNA
$23.6B
$18K 0.01%
124
-90
-42% -$12.9K
NWG icon
627
NatWest
NWG
$70.3B
$18K 0.01%
3,106
-1,973
-39% -$11.8K
RY icon
628
Royal Bank of Canada
RY
$292B
$18K 0.01%
183
-340
-65% -$34.8K
SHG icon
629
Shinhan Financial Group
SHG
$32.4B
$18K 0.01%
630
-1,095
-63% -$35.6K
XEL icon
630
Xcel Energy
XEL
$49.1B
$18K 0.01%
250
-79
-24% -$5.75K
CNR
631
Core Natural Resources Inc
CNR
$4.23B
$18K 0.01%
360
-695
-66% -$33.8K
ORAN
632
DELISTED
Orange
ORAN
$18K 0.01%
1,495
-4,580
-75% -$54.9K
AEG icon
633
Aegon
AEG
$13.4B
$17K ﹤0.01%
3,930
-6,692
-63% -$33.2K
MRVL icon
634
Marvell Technology
MRVL
$175B
$17K ﹤0.01%
396
+96
+32% +$5.44K
MUR icon
635
Murphy Oil
MUR
$5.28B
$17K ﹤0.01%
558
+145
+35% +$5.59K
PBR icon
636
Petrobras
PBR
$117B
$17K ﹤0.01%
1,470
-6,547
-82% -$90.6K
RGEN icon
637
Repligen
RGEN
$8.21B
$17K ﹤0.01%
105
-174
-62% -$27.5K
SIRI icon
638
SiriusXM
SIRI
$10.3B
$17K ﹤0.01%
276
SMFG icon
639
Sumitomo Mitsui Financial
SMFG
$158B
$17K ﹤0.01%
2,863
-11,294
-80% -$68.2K
STLD icon
640
Steel Dynamics
STLD
$33.2B
$17K ﹤0.01%
255
-355
-58% -$28.4K
BRO icon
641
Brown & Brown
BRO
$23.4B
$16K ﹤0.01%
273
-155
-36% -$9.51K
CSL icon
642
Carlisle Companies
CSL
$13.2B
$16K ﹤0.01%
66
-85
-56% -$21.2K
DBEF icon
643
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.03B
$16K ﹤0.01%
454
-6,546
-94% -$240K
EXPO icon
644
Exponent
EXPO
$3.04B
$16K ﹤0.01%
175
-290
-62% -$27.3K
FITB
645
Fifth Third Bancorp
FITB
$52B
$16K ﹤0.01%
480
+156
+48% +$5.86K
MBB icon
646
iShares MBS ETF
MBB
$39.2B
$16K ﹤0.01%
+162
New +$15.9K
TECH icon
647
Bio-Techne
TECH
$11.2B
$16K ﹤0.01%
180
-300
-63% -$28.1K
ACM icon
648
Aecom
ACM
$8.73B
$15K ﹤0.01%
230
-290
-56% -$20.3K
BCC icon
649
Boise Cascade
BCC
$2.67B
$15K ﹤0.01%
260
-360
-58% -$26.6K
BIO icon
650
Bio-Rad Laboratories Class A
BIO
$8.08B
$15K ﹤0.01%
30
-60
-67% -$31.2K

Similar funds

Fieldpoint Private Securities's Q2 2022 Portfolio in Review

As of Q2 2022, Fieldpoint Private Securities held 1,793 positions worth $344M, down 29% from $485M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Fieldpoint Private Securities withdrew a net $78.3M in Q2 2022, closing 244 positions and reducing 1,081 holdings. Its most notable exit was State Street SPDR S&P Dividend ETF, an estimated $911K position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Fieldpoint Private Securities opened a new position in WisdomTree US MidCap Dividend Fund worth $3.48M.

  • Fieldpoint Private Securities's largest Q2 2022 buy was WisdomTree US MidCap Dividend Fund: 89,302 shares worth $3.48M.
  • Fieldpoint Private Securities added most to iShares International Select Dividend ETF in Q2 2022, an estimated $7M increase.
  • Fieldpoint Private Securities's biggest Q2 2022 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $3.61M.
  • Fieldpoint Private Securities fully exited State Street SPDR S&P Dividend ETF in Q2 2022, selling an estimated $911K.
  • Fieldpoint Private Securities's ten largest holdings make up 23% of its $344M portfolio in Q2 2022.
  • Fieldpoint Private Securities opened 93 new positions and closed 244 in Q2 2022.
  • Fieldpoint Private Securities's portfolio value fell 29% quarter-over-quarter to $344M.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.